231 related articles for article (PubMed ID: 21847101)
1. Erythropoietin gene-enhanced marrow mesenchymal stromal cells decrease cisplatin-induced kidney injury and improve survival of allogeneic mice.
Eliopoulos N; Zhao J; Forner K; Birman E; Young YK; Bouchentouf M
Mol Ther; 2011 Nov; 19(11):2072-83. PubMed ID: 21847101
[TBL] [Abstract][Full Text] [Related]
2. Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection.
Eliopoulos N; Zhao J; Bouchentouf M; Forner K; Birman E; Yuan S; Boivin MN; Martineau D
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1288-98. PubMed ID: 20844023
[TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin on the migration of bone marrow-derived mesenchymal stem cells to the acute kidney injury microenvironment.
Liu N; Tian J; Cheng J; Zhang J
Exp Cell Res; 2013 Aug; 319(13):2019-2027. PubMed ID: 23624354
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.
Qi S; Wu D
Int J Mol Med; 2013 Dec; 32(6):1262-72. PubMed ID: 24126885
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation.
Liu N; Han G; Cheng J; Huang J; Tian J
Exp Biol Med (Maywood); 2013 Jun; 238(6):678-86. PubMed ID: 23918879
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms.
Cheng K; Rai P; Plagov A; Lan X; Kumar D; Salhan D; Rehman S; Malhotra A; Bhargava K; Palestro CJ; Gupta S; Singhal PC
Exp Mol Pathol; 2013 Jun; 94(3):466-73. PubMed ID: 23534987
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin expands a stromal cell population that can mediate renoprotection.
Bi B; Guo J; Marlier A; Lin SR; Cantley LG
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1017-22. PubMed ID: 18653480
[TBL] [Abstract][Full Text] [Related]
8. Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease.
Wang Y; Lu X; He J; Zhao W
Stem Cell Res Ther; 2015 May; 6(1):100. PubMed ID: 25998259
[TBL] [Abstract][Full Text] [Related]
9. Intra-renal arterial injection of autologous bone marrow mesenchymal stromal cells ameliorates cisplatin-induced acute kidney injury in a rhesus Macaque mulatta monkey model.
Moghadasali R; Azarnia M; Hajinasrollah M; Arghani H; Nassiri SM; Molazem M; Vosough A; Mohitmafi S; Najarasl M; Ajdari Z; Yazdi RS; Bagheri M; Ghanaati H; Rafiei B; Gheisari Y; Baharvand H; Aghdami N
Cytotherapy; 2014 Jun; 16(6):734-49. PubMed ID: 24801377
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of allogenic and xenogeneic mesenchymal stem cells on cisplatin-induced acute kidney injury in Sprague-Dawley rats.
Ashour RH; Saad MA; Sobh MA; Al-Husseiny F; Abouelkheir M; Awad A; Elghannam D; Abdel-Ghaffar H; Sobh M
Stem Cell Res Ther; 2016 Sep; 7(1):126. PubMed ID: 27585525
[TBL] [Abstract][Full Text] [Related]
11. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
Jiao X; Cai J; Yu X; Ding X
Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
[TBL] [Abstract][Full Text] [Related]
12. The neuroprotective effect of erythropoietin-transduced human mesenchymal stromal cells in an animal model of ischemic stroke.
Cho GW; Koh SH; Kim MH; Yoo AR; Noh MY; Oh S; Kim SH
Brain Res; 2010 Sep; 1353():1-13. PubMed ID: 20547143
[TBL] [Abstract][Full Text] [Related]
13. Bone mesenchymal stem cells pretreated with erythropoietin enhance the effect to ameliorate cyclosporine A-induced nephrotoxicity in rats.
Zhou S; Liu YG; Zhang Y; Hu JM; Liu D; Chen H; Li M; Guo Y; Fan LP; Li LY; Zhao M
J Cell Biochem; 2018 Nov; 119(10):8220-8232. PubMed ID: 29932236
[TBL] [Abstract][Full Text] [Related]
14. Kidney Mesenchymal Stem Cell-derived Extracellular Vesicles Engineered to Express Erythropoietin Improve Renal Anemia in Mice with Chronic Kidney Disease.
Choi HY; Kim TY; Lee M; Kim SH; Jhee JH; Lee YK; Kim HJ; Park HC
Stem Cell Rev Rep; 2022 Mar; 18(3):980-992. PubMed ID: 33651336
[TBL] [Abstract][Full Text] [Related]
15. Bone-derived mesenchymal stromal cells from HIV transgenic mice exhibit altered proliferation, differentiation capacity and paracrine functions along with impaired therapeutic potential in kidney injury.
Cheng K; Rai P; Lan X; Plagov A; Malhotra A; Gupta S; Singhal PC
Exp Cell Res; 2013 Aug; 319(14):2266-74. PubMed ID: 23806280
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from induced pluripotent stem cell-derived mesenchymal stem cells enhance the recovery of acute kidney injury.
Hong S; Kim H; Kim J; Kim S; Park TS; Kim TM
Cytotherapy; 2024 Jan; 26(1):51-62. PubMed ID: 37843481
[TBL] [Abstract][Full Text] [Related]
17. Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects
Rendra E; Crigna AT; Daniele C; Sticht C; Cueppers M; Kluth MA; Ganss C; Frank MH; Gretz N; Bieback K
Front Immunol; 2023; 14():1228928. PubMed ID: 38274791
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.
Campeau PM; Rafei M; François M; Birman E; Forner KA; Galipeau J
Mol Ther; 2009 Feb; 17(2):369-72. PubMed ID: 19088705
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of bone marrow-derived mesenchymal stem cells and/or erythropoietin in ameliorating kidney damage in gamma irradiated rats: Role of non-hematopoietic erythropoietin anti-apoptotic signaling.
Asker ME; Ali SI; Mohamed SH; Abdelaleem RMA; Younis NN
Life Sci; 2021 Jun; 275():119388. PubMed ID: 33774028
[TBL] [Abstract][Full Text] [Related]
20. Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury.
Gheisari Y; Azadmanesh K; Ahmadbeigi N; Nassiri SM; Golestaneh AF; Naderi M; Vasei M; Arefian E; Mirab-Samiee S; Shafiee A; Soleimani M; Zeinali S
Stem Cells Dev; 2012 Nov; 21(16):2969-80. PubMed ID: 22563951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
